The prevalence of carbapenem resistance throughout the world is increasing and carbapenems are considered critically important antimicrobials by the WHO. The aim of study is to evaluate clinical and antibiotic resistance impact of carbapenems Antibiotic Stewardship Programs (ASP).
Póster presentado en: 30º ECCMID-European Congress of Clinical Microbiology and Infectious Diseases celebrado en París del 18 al 21 de abril de 2020